Beijing, 100069
China
Capital Medical University - Department of Infectious Diseases
HIV, AIDS, nivolumab, pembrolizumab, avelumab, atezolizumab, durvalumab, anti-PD-1, anti-PD-L1
TDF; Immunological effects; Meta-analysis; HIV; HBV; Coinfection
Ainuovirine, Switch therapy, Non-inferiority, Weight gain, Dyslipidaemia
HIV, low-level viraemia, prevalence, risk factors, virological failure
B cells, T follicular helper cells, ICOS, Acute HIV-1 infection